Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals, Inc. (PHAT) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
phat · stock forecast · 9 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 9 Wall Street analysts in the past 3 months
Buy
9 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$28.00
Consensus
$24.67
+151.9% upside
Low
$18.00
Median: $28 · Last Close: $9.79
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$24.67
151.9% upside
High Target
$28
185.9%
Low Target
$18
83.8%
Current Price
$9.79
as of today
Based on analyst price targets, the PHAT stock price prediction for the next 12 months ranges from $18 to $28. The consensus PHAT price forecast of $24.67 implies 151.9% upside from the current price of $9.79.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $9.31 | ↓ 5.00% |
1-day model range: $9.24–$9.37. Peak: $9.37 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $13 | +30.2% |
| 2028 | $15 | +51.8% |
| 2029 | $16 | +65.7% |
| 2030 | $17 | +74.0% |
| 2031 | — | +78.9% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PHAT · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-27 | Barclays | Upgrade ↑ | Equal Weight→Overweight |
| 2026-02-27 | Guggenheim | Maintains | Buy→Buy |
| 2025-10-31 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-06-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-06-09 | Craig-Hallum | Maintains | Buy→Buy |
| 2025-06-06 | Needham | Maintains | Buy→Buy |
| 2025-05-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-02 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2025-05-02 | Guggenheim | Maintains | Buy→Buy |
| 2025-05-02 | Craig-Hallum | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Phathom Pharmaceuticals, Inc. (PHAT) stock. Of the recent 91 rating actions, 3 were upgrades and 2 were downgrades. 9 analysts currently cover PHAT.
Analyst Recommendation Trends
PHAT analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$334M
↓ 55.8% YoY
Revenue Next Year
$540M
↑ 61.6% YoY
EPS This Year
$-0.62
EPS Next Year
$1.19
↓ 291.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast PHAT EPS of $-0.62 for the current fiscal year, based on estimates from 3 analysts. The PHAT revenue forecast is $334M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The PHAT stock forecast is supported by two independent data sources: analyst consensus ratings from 9 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PHAT price target is $24.67 (+151.9% upside), with an analyst consensus of Buy.
The PHAT short-term stock prediction for tomorrow is $9.31 (-5.00%). The PHAT stock price prediction for 2027 estimates an average of $13. The PHAT stock prediction for 2030 projects a range of $16–$18.
Phathom Pharmaceuticals, Inc. trades on NASDAQ under the ticker PHAT. The PHAT stock outlook for 2027 is broadly positive, supported by a Buy consensus among 89% of covering analysts.
Frequently asked questions
PHAT forecast · 8 questionsAccording to 9 Wall Street analysts, the average 12-month PHAT price target is $24.67, with a high forecast of $28.00 and a low of $18.00. The median price target is shown in the chart above when available. This implies +151.9% potential upside from the current price of $9.79.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.